Author Information
Mark W. Tenforde is affiliated with the Division of Allergy and Infectious Diseases at the Department of Medicine, University of Washington School of Medicine, located in Seattle, WA, USA. He is also associated with the Department of Epidemiology at the University of Washington School of Public Health. Additionally, he is connected to the Botswana-UPenn Partnership in Gaborone, Botswana. His work primarily revolves around infectious diseases, with a strong focus on COVID-19 research, particularly in vaccine effectiveness and clinical outcomes.Research Contributions
Mark W. Tenforde has made significant contributions to the field of infectious diseases, with a particular emphasis on COVID-19. His research has explored the effectiveness of mRNA vaccines, including the Pfizer-BioNTech and Moderna vaccines, in preventing COVID-19 hospitalizations and severe outcomes among different populations, including immunocompromised individuals and children. He has also studied the effectiveness of vaccines against various SARS-CoV-2 variants such as Omicron, Delta, and Alpha. His work extends to examining the long-term health impacts of COVID-19 and understanding clinical severity associated with the disease.Aliases
Mark W. Tenforde is also known by several aliases, including M W Tenforde, M Tenforde, Mark Tenforde, and M. W. Tenforde. These variations of his name are used across different publications and platforms.Publication and Citation Metrics
| Metric |
Value |
| Citation Count |
8550 |
| H-index |
36 |
| Paper Count |
131 |
